These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22583447)

  • 1. Editorial: Status of tyrosine hydroxylase in the healthy and Parkinson's brain.
    Kamal MA
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):336-9. PubMed ID: 22583447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkinson's disease].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1801-14. PubMed ID: 6152497
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic enzyme systems in Parkinson's disease.
    McGeer PL; McGeer EG
    Arch Neurol; 1971 Sep; 25(3):265-8. PubMed ID: 4157296
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinson's disease. A genetic study.
    Martin WE; Young WI; Anderson VE
    Brain; 1973 Sep; 96(3):495-506. PubMed ID: 4147573
    [No Abstract]   [Full Text] [Related]  

  • 5. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
    Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D
    J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains.
    Nakashima S; Ikuta F
    J Neurol Sci; 1984 Oct; 66(1):91-6. PubMed ID: 6151589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of tyrosine hydroxylase in Parkinson's disease.
    Zhu Y; Zhang J; Zeng Y
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):350-8. PubMed ID: 22483316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.
    Gai WP; Vickers JC; Blumbergs PC; Blessing WW
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Parkinson's - tyrosine hydroxylase and oxidative stress as points of interventions.
    Khan MS; Tabrez S; Priyadarshini M; Priyamvada S; Khan MM
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):369-80. PubMed ID: 22483312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.
    McGeer PL; McGeer EG
    J Neurochem; 1976 Jan; 26(1):65-76. PubMed ID: 3629
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry of tyrosine hydroxylase].
    Nagatsu S
    Seikagaku; 1976; 48(12):1108-11. PubMed ID: 16066
    [No Abstract]   [Full Text] [Related]  

  • 14. The function of tyrosine hydroxylase in the normal and Parkinsonian brain.
    Tolleson C; Claassen D
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):381-6. PubMed ID: 22483314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.
    Yokochi M; Narabayashi H; Iizuka R; Nagatsu T
    Adv Neurol; 1984; 40():407-13. PubMed ID: 6141711
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotransmitter synthetic enzymes.
    McGeer PL; McGeer EG
    Prog Neurobiol; 1973; 2(1):69-117. PubMed ID: 4149290
    [No Abstract]   [Full Text] [Related]  

  • 18. Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity.
    Nagatsu T
    Neurochem Res; 1990 Apr; 15(4):425-9. PubMed ID: 1975089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
    Hurley MJ; Mash DC; Jenner P
    Eur J Neurosci; 2003 Nov; 18(9):2668-72. PubMed ID: 14622169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease.
    White RB; Thomas MG
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):340-9. PubMed ID: 22483315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.